Evidence map›Paper›PMID 40155950›Full record

ArticleJournal of nanobiotechnology2025

Scalable ion concentration polarization dialyzer for peritoneal dialysate regeneration.

Wonseok Kim, Seongjun Hong, Kihong Kim, Sunhwa Lee, Dong Ah Shin, Seung Hee Yang, Jeongeun Lee, Kyunghee Kim, Kyoung Jin Lee, Woo Sang Cho and 7 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Wonseok Kim *Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
Seongjun Hong *Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
Kihong Kim *Department of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea.
Sunhwa Lee *Division of Nephrology, Kangwon National University Hospital, Chuncheon, 24289, Republic of Korea.
Dong Ah ShinInterdisciplinary Program in Bioengineering, Graduate School, Seoul National University, Seoul, 08826, Republic of Korea.
Seung Hee YangKidney Research Institute, Seoul National University Medical Research Center, Seoul, 03080, Republic of Korea.
Jeongeun LeeMajor in Materials Science and Engineering, School of Future Convergence, Hallym University, Chuncheon, 24252, Republic of Korea.
Kyunghee KimMajor in Materials Science and Engineering, School of Future Convergence, Hallym University, Chuncheon, 24252, Republic of Korea.
Kyoung Jin LeeInterdisciplinary Program in Bioengineering, Graduate School, Seoul National University, Seoul, 08826, Republic of Korea.
Woo Sang ChoInterdisciplinary Program in Bioengineering, Graduate School, Seoul National University, Seoul, 08826, Republic of Korea.
Hajeong LeeDivision of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Dong Ki KimDivision of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea.
Hee Chan KimInstitute of Medical and Biological Engineering, Seoul National University Medical Research Center, Seoul, 03080, Republic of Korea.
Yon Su KimDivision of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, 03080, Republic of Korea. yonsukim@snu.ac.kr.
Jung Chan LeeInstitute of Medical and Biological Engineering, Seoul National University Medical Research Center, Seoul, 03080, Republic of Korea. ljch@snu.ac.kr.
Gun Yong SungMajor in Materials Science and Engineering, School of Future Convergence, Hallym University, Chuncheon, 24252, Republic of Korea. gysung@hallym.ac.kr.
Sung Jae KimDepartment of Electrical and Computer Engineering, Seoul National University, Seoul, 08826, Republic of Korea. gates@snu.ac.kr.

Funding

Ministry of Health and Welfare Republic of Korea HI14C0559020019Ministry of Science and ICT, South Korea NRF-2020R1A2C3006162Ministry of Science and ICT, South Korea NRF-2021R1C1C2012603
6 · The paper itself

Abstract

A wearable artificial kidney (WAK) stands poised to offer dialysis treatment with maximal temporal and spatial flexibility for end-stage renal disease (ESRD) patients, while portability has not yet been achieved due to difficulties in portable purification. The ion concentration polarization (ICP), one of the nanoelectrokinetic phenomenon, has garnered substantial attention in the realm of portable purification applications, owing to its remarkable capacity for charge separation. In this work, scalable ICP dialyzer with 10,000-fold increase in throughput, was applied for peritoneal dialysate regeneration. First, the mechanism underpinning dialysate purification was corroborated based on micro-nanofluidics. Simultaneously, the electrochemical reactions utilized the complete decomposition of uncharged toxin (urea), achieving approximately 99% clearance, while the ICP phenomenon promoted the removal of positively charged toxin (creatinine), achieving approximately 30% clearance. Second, 3-D scalable ICP dialyzer was developed with a creation of micro-nanofluidic environment inside. Throughput scalability was demonstrated up to 1 mL/min with average approximately 30% toxins clearance. Ultimately, the 3-D ICP dialyzer was applied to assist peritoneal dialysis (PD) using a bilateral nephrectomy rat model. We demonstrated that regenerated dialysate successfully reduced in vivo toxicity, with average toxins removal ratio of approximately 30% per cycle. We believe that the integration of this scalable ICP dialyzer into the WAK holds tremendous potential for substantially enhancing the quality of life for individuals with ESRD.

Indexed as

Dialysis SolutionsPeritoneal DialysisAnimalsKidney Failure, ChronicKidneys, ArtificialMaleRatsRats, Sprague-DawleyUreaDialysis SolutionsUrea

Identifiers

PMID40155950
PMCPMC11954356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.